Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition.

MLA

Mueller, Sandra M., et al. “Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 56, no. 2, Feb. 2011, pp. 109–17. EBSCOhost, https://doi.org/10.1097/QAI.0b013e3181fe946e.

APA

Mueller, S. M., Spriewald, B. M., Bergmann, S., Eismann, K., Leykauf, M., Korn, K., Walter, H., Schmidt, B., Arnold, M.-L., Harrer, E. G., Kaiser, R., Schweitzer, F., Braun, P., Reuter, S., Jaeger, H., Wolf, E., Brockmeyer, N. H., Jansen, K., Michalik, C., & Harrer, T. (2011). Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition. Journal of Acquired Immune Deficiency Syndromes (1999), 56(2), 109–117. https://doi.org/10.1097/QAI.0b013e3181fe946e

Chicago

Mueller, Sandra M, Bernd M Spriewald, Silke Bergmann, Kathrin Eismann, Melanie Leykauf, Klaus Korn, Hauke Walter, et al. 2011. “Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition.” Journal of Acquired Immune Deficiency Syndromes (1999) 56 (2): 109–17. doi:10.1097/QAI.0b013e3181fe946e.